Common Contracts
2 similar Master Collaborative Research Agreement contracts by Lexaria Bioscience Corp.
Lexaria Signs Master Collaborative Research AgreementMaster Collaborative Research Agreement • February 14th, 2017 • Lexaria Bioscience Corp. • Metal mining
Kelowna, BC / February 8, 2017 / Lexaria Bioscience Corp. (OTCQB:LXRP) (CSE:LXX) (“the Company” or “Lexaria”), through its wholly owned Canadian subsidiary Lexaria Canpharm Corp., has signed and entered a master collaborative research agreement with the National Research Council of Canada (NRC) to investigate technical aspects and new opportunities associated with bioavailability enhancement of lipophilic active ingredient compositions.
Lexaria Signs Master Collaborative Research AgreementMaster Collaborative Research Agreement • February 7th, 2017
Lexaria believes that results from this scientific collaboration could motivate license adoption of Lexaria’s patented flavour masking and nutrient delivery enhancement technology, including but not limited to the vitamin, pain reliever and nicotine sectors. Lexaria’s technology is patented in the US, and patent pending in Canada and in 41 other countries around the world.
